Contributor

B. David Zarley

Contact

B. David Zarley is freelance journalist covering health and medicine, including infectious disease, psychedelic research, mental health, and the brain. A graduate of SUNY Fredonia, his work has appeared in The Atlantic, The Verge, Jezebel, Frieze, Sports Illustrated, VICE, Paste Magazine, and numerous other publications.

Virology

As Ebola reaches Ugandan capital, vaccines race to catch up

Caused by the Sudan strain of Ebola, current vaccines and therapies approved for Ebola won’t work in Uganda. But these might.

B. David Zarley

Medicine

UK scientists solve a decades-long blood mystery

Researchers have discovered a new blood group which may have been behind the tragic loss of two babies.

B. David Zarley

Medicine

Cambridge researchers have discovered how cancer spreads

New research out of the University of Cambridge may have discovered a mechanism behind metastasis.

B. David Zarley

Medicine

New test catches deadly bloodstream infections much faster

Bloodstream infections have a high mortality rate. But a new test to catch them faster could lead to more saved lives.

B. David Zarley

Virology

A newly discovered class of RNA can fight off multiple viruses, including flu and SARS-CoV-2

Harvard-affiliated researchers have discovered a form of double-stranded RNA which may be a potent antiviral.

B. David Zarley

Medicine

Tiny robots completely clear out deadly pneumonia infection in mice

Researchers have created microscopic robots capable of clearing pneumonia from the lungs of mice.

B. David Zarley

Medicine

A modified herpes virus completely wiped out a terminal cancer

In a small phase 1 trial of a herpes-based cancer therapy, one patient had their tumors completely eliminated.

B. David Zarley

Criminal Justice

Biden pardons federal cannabis possession cases, urges states to do the same

The Biden administration is pardoning federal possession offenses, encouraging states to do the same, and reexamining its drug scheduling.

B. David Zarley

Neuroscience

New Alzheimer’s drug slows mental decline by 27% in clinical trial

Eisai and Biogen are reporting that their new Alzheimer’s antibody slowed cognitive decline by 27% in a global trial.

B. David Zarley

Brain

Shape-shifting DNA is helping researchers decode the human brain

Researcher Nako Nakatsuka has turned to DNA to tackle an important challenge: how do we measure chemicals in the brain?

B. David Zarley